• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

明确的局部缺血对犬模型心肌溶酶体和微粒体酶的影响。

Effects of well-defined ischemia on myocardial lysosomal and microsomal enzymes in a canine model.

作者信息

Kennett F F, Weglicki W B

出版信息

Circ Res. 1978 Nov;43(5):750-8. doi: 10.1161/01.res.43.5.750.

DOI:10.1161/01.res.43.5.750
PMID:213202
Abstract

We have used a new technique for extraction of myocardial membranes (0.25 M sucrose, 0.6 M KCl) to isolate particulate and soluble proteins and enzymatic activities in an effort to quantify changes characteristic of progressive ischemia. Myocardial blood flow (MBF) was measured with microspheres (15 micrometer diameter) in all samples of tissue used for assay of proteins and enzymatic activities; MBF to the moderately ischemic areas (M-ischemia) was 53% of control (H-control); MBF to the severely ischemic areas (L-ischemia) was 9% of control. Significant decreases (P less than 0.001) in content of protein were seen in all post 1,000 g pellets and supernatant fluids in the L-ischemia zones; particulate lysosomal enzymatic activity was significantly decreased (P less than 0.001) in all four post 1,000 g pellets (2,500 g to 140,000 g) of the L-ischemic areas (for N-acetyl-beta-glucosaminidase and beta-glucuronidase). The increase in percent free activity of lysosomal enzymes (index of loss of latency) also was highly significant (P less than 0.001) in all particulate fractions of the L-ischemic areas. In addition, about 45% of the total activity of the microsomal marker enzyme, rotenone-insensitive NADH cytochrome C reductase (RINCR), was found in the 140,000 g pellet of H-control tissue (9.9 micronmol/min per g); this activity fell to 8.1 micronmol/min per g in M-ischemic areas (P less than 0.001) and to 5.3 micronmol/min per g in L-ischemic areas (P less than 0.001). This study demonstrates that changes in myocardial proteins, lysosomes, and other membrane-bound enzymes (RINCR) may provide reproducible bichemical parameters for assessing ischemic myocardial injury.

摘要

我们采用了一种提取心肌膜的新技术(0.25M蔗糖,0.6M氯化钾)来分离颗粒性和可溶性蛋白质以及酶活性,以量化进行性缺血的特征性变化。在用于蛋白质和酶活性测定的所有组织样本中,用微球(直径15微米)测量心肌血流量(MBF);中度缺血区域(M-缺血)的MBF为对照(H-对照)的53%;重度缺血区域(L-缺血)的MBF为对照的9%。在L-缺血区域的所有1000g沉淀物和上清液中,蛋白质含量均显著降低(P<0.001);L-缺血区域的所有四个1000g沉淀物(2500g至140000g)中,颗粒性溶酶体酶活性显著降低(P<0.001)(针对N-乙酰-β-葡萄糖苷酶和β-葡萄糖醛酸酶)。L-缺血区域所有颗粒部分中溶酶体酶的游离活性百分比增加(潜伏性丧失指数)也非常显著(P<0.001)。此外,微粒体标记酶鱼藤酮不敏感的NADH细胞色素C还原酶(RINCR)的总活性中,约45%存在于H-对照组织的140000g沉淀物中(9.9微摩尔/分钟每克);该活性在M-缺血区域降至8.1微摩尔/分钟每克(P<0.001),在L-缺血区域降至5.3微摩尔/分钟每克(P<0.001)。这项研究表明,心肌蛋白质、溶酶体和其他膜结合酶(RINCR)的变化可能为评估缺血性心肌损伤提供可重复的生化参数。

相似文献

1
Effects of well-defined ischemia on myocardial lysosomal and microsomal enzymes in a canine model.明确的局部缺血对犬模型心肌溶酶体和微粒体酶的影响。
Circ Res. 1978 Nov;43(5):750-8. doi: 10.1161/01.res.43.5.750.
2
Lack of effect of methylprednisolone on lysosomal and microsomal enzymes after two hours of well-defined canine myocardial ischemia.在明确界定的犬心肌缺血两小时后,甲基强的松龙对溶酶体酶和微粒体酶无影响。
Circ Res. 1978 Nov;43(5):759-68. doi: 10.1161/01.res.43.5.759.
3
Lysosomal changes in an animal model of myocardial ischemia. Treatment with methylprednisolone.心肌缺血动物模型中的溶酶体变化。甲基强的松龙治疗。
Adv Myocardiol. 1980;2:371-81.
4
Effect of collateral flow on epicardial and endocardial lysosomal hydrolases in acute myocardial ischemia.侧支血流对急性心肌缺血时心外膜和心内膜溶酶体水解酶的影响。
J Clin Invest. 1975 Oct;56(4):914-23. doi: 10.1172/JCI108171.
5
Release of lysosomal enzymes during ischemic injury of canine myocardium.犬心肌缺血损伤期间溶酶体酶的释放。
Recent Adv Stud Cardiac Struct Metab. 1976;12:431-8.
6
Acid hydrolases in the initiation of ischemic myocardial necrosis.
Adv Myocardiol. 1983;4:363-9. doi: 10.1007/978-1-4757-4441-5_33.
7
Inhibition of myocardial rotenone-insensitive NADH cytochrome c reductase by amphiphilic compounds.
Am J Physiol. 1984 Dec;247(6 Pt 2):H889-94. doi: 10.1152/ajpheart.1984.247.6.H889.
8
Ischemia-induced alterations in myocardial (Na+ + K+)-ATPase and cardiac glycoside binding.缺血诱导的心肌(钠+钾)-ATP酶及强心苷结合的改变。
J Clin Invest. 1976 Feb;57(2):341-50. doi: 10.1172/JCI108285.
9
Studies on intracardiac acid hydrolases in the ischemic myocardial necrosis.
Jpn Circ J. 1982 Dec;46(12):1337-44. doi: 10.1253/jcj.46.1337.
10
Lysosomal hypothesis in evolution of myocardial infarction. Subcellular fractionation and electron microscopic cytochemical study.心肌梗死演变中的溶酶体假说。亚细胞分级分离及电子显微镜细胞化学研究。
Jpn Heart J. 1979 Sep;20(5):643-56. doi: 10.1536/ihj.20.643.

引用本文的文献

1
Effect of nicorandil and amlodipine on bio-chemical parameters during isoproterenol induced myocardial necrosis in rats.尼可地尔和氨氯地平对异丙肾上腺素诱导的大鼠心肌坏死过程中生化参数的影响。
Indian J Clin Biochem. 2003 Jan;18(1):99-102. doi: 10.1007/BF02867674.
2
Protective effect of Terminalia chebula against lysosomal enzyme alterations in isoproterenol-induced cardiac damage in rats.诃子对异丙肾上腺素诱导的大鼠心脏损伤中溶酶体酶改变的保护作用。
Exp Clin Cardiol. 2005 Summer;10(2):91-5.
3
Sphingosylphosphocholine, a signaling molecule which accumulates in Niemann-Pick disease type A, stimulates DNA-binding activity of the transcription activator protein AP-1.
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5885-9. doi: 10.1073/pnas.92.13.5885.
4
Are lysosomal enzymes involved in rapid damage in vertebrate muscle cells? A study of the separate pathways leading to cellular damage.溶酶体酶是否参与脊椎动物肌肉细胞的快速损伤?对导致细胞损伤的不同途径的研究。
Cell Tissue Res. 1988 Aug;253(2):447-55. doi: 10.1007/BF00222302.
5
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.β受体阻滞剂、普萘洛尔、比索洛尔和尼普地洛在犬局部缺血模型中的心脏保护和抗心律失常作用
Heart Vessels. 1989;5(1):10-6. doi: 10.1007/BF02058353.
6
Effects of antiarrhythmic agents classified as class III group on ischaemia-induced myocardial damage in canine hearts.III类抗心律失常药物对犬心脏缺血性心肌损伤的影响。
Br J Pharmacol. 1990 Mar;99(3):577-81. doi: 10.1111/j.1476-5381.1990.tb12971.x.